ECM
VBIV

ExodusPoint Capital Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

ExodusPoint Capital Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-861
Closed -$18K – 2256
2022
Q3 		$18K Sell
861
-5,109
-86% -$138K ﹤0.01% 1810
2022
Q2 		$145K Buy
5,970
+5,198
+673% +$177K ﹤0.01% 1705
2022
Q1 		$38K Sell
772
-653
-46% -$32.3K ﹤0.01% 2082
2021
Q4 		$100K Buy
+1,425
New +$120K ﹤0.01% 1952
2021
Q3 		– Sell
-2,585
Closed -$260K – 2778
2021
Q2 		$260K Buy
2,585
+1,887
+270% +$184K ﹤0.01% 1827
2021
Q1 		$65K Buy
+698
New +$70.8K ﹤0.01% 2013
2019
Q4 		– Sell
-4,830
Closed -$68K – 1984
2019
Q3 		$68K Buy
+4,830
New +$101K ﹤0.01% 1261
2019
Q2 		– Sell
-1,410
Closed -$79K – 1391
2019
Q1 		$79K Buy
+1,410
New +$76.3K 0.01% 621

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return